Charles Schwab’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.1M | Sell |
188,202
-8,292
| -4% | -$181K | ﹤0.01% | 2413 |
|
|
2025
Q1 | $3.63M | Sell |
196,494
-9,885
| -5% | -$183K | ﹤0.01% | 2406 |
|
|
2024
Q4 | $5.5M | Buy |
206,379
+4,011
| +2% | +$107K | ﹤0.01% | 2297 |
|
|
2024
Q3 | $4.76M | Buy |
202,368
+122,641
| +154% | +$2.88M | ﹤0.01% | 2398 |
|
|
2024
Q2 | $1.48M | Buy |
79,727
+1,967
| +3% | +$36.5K | ﹤0.01% | 2794 |
|
|
2024
Q1 | $1.39M | Buy |
+77,760
| New | +$1.39M | ﹤0.01% | 2698 |
|